NRX Pharmaceuticals, Inc. Marketable Securities, Unrealized Gain (Loss)
NRX Pharmaceuticals, Inc. (NRXP) reported Marketable Securities, Unrealized Gain (Loss) of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2019-11-14
- NRX Pharmaceuticals, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2019-09-30 was $0.00.
- NRX Pharmaceuticals, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2019-03-31 was $0.00.
- NRX Pharmaceuticals, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2018-12-31 was $0.00.
- NRX Pharmaceuticals, Inc. marketable securities, unrealized gain (loss) for fiscal 2018 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-08-14 | -$74.00 derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | $0.00 derived: sum of 2 quarters · filed 2019-05-15 | -$74.00 derived: sum of 3 quarters · filed 2019-11-14 | $1.60K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$74.00 derived: sum of 2 quarters · filed 2019-11-14 | $1.60K derived: sum of 3 quarters · filed 2019-11-14 | $0.00 10-K · filed 2019-03-15 |
| 2018-09-30 | -$74.00 10-Q · filed 2019-11-14 | $1.60K derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.67K 10-Q · filed 2019-08-14 | $75.00 10-Q · filed 2019-08-14 | -$4.67K derived: sum of 3 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$1.60K 10-Q · filed 2019-05-15 | -$6.34K derived: sum of 2 quarters · filed 2019-05-15 | ||
| 2017-12-31 | -$4.74K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |